NDAQ:OCEA - Post Discussion
Post by
JasleenDhaka on May 04, 2023 5:44pm
Anti-Chi3L1 antibody shows promising results
@OceanBiomedical's Anti-Chi3L1 antibody shows promising results, suppressing glioblastoma tumor growth by 60%. A major milestone as they file an application for human clinical trials with the FDA.
read this news: https://www.researchfrc.com/our-prediction-for-the-feds-meeting-this-week/
Be the first to comment on this post